WO2003018793A1 - Novel gene having guanine nucleotide exchange factor-like sequence - Google Patents

Novel gene having guanine nucleotide exchange factor-like sequence Download PDF

Info

Publication number
WO2003018793A1
WO2003018793A1 PCT/JP2002/008408 JP0208408W WO03018793A1 WO 2003018793 A1 WO2003018793 A1 WO 2003018793A1 JP 0208408 W JP0208408 W JP 0208408W WO 03018793 A1 WO03018793 A1 WO 03018793A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
guanine nucleotide
nucleotide exchange
exchange factor
same
Prior art date
Application number
PCT/JP2002/008408
Other languages
French (fr)
Japanese (ja)
Inventor
Shuichiro Inagaki
Yoshihiro Kawamura
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Priority to JP2003523642A priority Critical patent/JP4219808B2/en
Publication of WO2003018793A1 publication Critical patent/WO2003018793A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A novel polypeptide having a human and mouse guanine nucleotide exchange factor-like (SecL-1) sequence and a gene encoding the same; a recombinant polypeptide using the DNA sequence encoding the above polypeptide and a process for producing the same; an antibody specifically recognizing it and a process for producing the same; a cell proliferation inhibitor, an apoptosis inducing agent and a remedy for liver diseases containing it; a method of screening a compound which specifically controlls the above protein with the use of it, etc.
PCT/JP2002/008408 2001-08-23 2002-08-21 Novel gene having guanine nucleotide exchange factor-like sequence WO2003018793A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003523642A JP4219808B2 (en) 2001-08-23 2002-08-21 A novel gene with a guanine nucleotide exchange factor-like sequence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001253344 2001-08-23
JP2001-253344 2001-08-23

Publications (1)

Publication Number Publication Date
WO2003018793A1 true WO2003018793A1 (en) 2003-03-06

Family

ID=19081693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008408 WO2003018793A1 (en) 2001-08-23 2002-08-21 Novel gene having guanine nucleotide exchange factor-like sequence

Country Status (2)

Country Link
JP (1) JP4219808B2 (en)
WO (1) WO2003018793A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (en) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001029221A2 (en) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Proteins and polynucleotides encoding them
WO2001032676A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 human secreted proteins
WO2001053453A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (en) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001029221A2 (en) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Proteins and polynucleotides encoding them
WO2001032676A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 human secreted proteins
WO2001053453A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACHSTETTER T. ET AL.: "SEC7 encodes an unusual, high molecular weight protein required for membrane traffic from the yeast golgi apparatus", J. BIOL. CHEM., vol. 263, no. 24, 1988, pages 11711 - 11717, XP002040610 *
AKIRA TOGAWA ET AL.: "Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors", J. BIOL. CHEM., vol. 274, no. 18, 1999, pages 12308 - 12315, XP002966803 *
MORINAGA N. ET AL.: "Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor", PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 12926 - 12931, XP002966802 *

Also Published As

Publication number Publication date
JP4219808B2 (en) 2009-02-04
JPWO2003018793A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
WO2001018172A3 (en) Fibroblast growth factor-like polypeptides
WO2001070174A8 (en) Vegf-modulated genes and methods employing them
WO2002074979A3 (en) Expression profiles and methods of use
DK2230299T3 (en) Hitherto unknown cytokine ZCYTOR17 ligand
WO2003016475A3 (en) Nucleic acid and amino acid sequences involved in pain
WO2003052118A3 (en) Bgl4 beta-glucosidase and nucleic acids encoding the same
WO2003020916A8 (en) Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
FI962247A (en) Novel apoptosis-transforming proteins, DNA encoding them, and methods for their use
DE60313866D1 (en) POLYPEPTIDE WITH ALPHA-H ALPHA AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS CODED THEREFOR
WO2004053137A3 (en) Method for protein production
DK1098991T3 (en) New methods for identifying ligand and target biomolecules
BR0214542A (en) Host cell, expression system, and processes for preparing a host cell and a target protein
AU2002323249A1 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
WO2001016324A3 (en) Methods and compositions of a novel serine protease inhibitor
WO2003018793A1 (en) Novel gene having guanine nucleotide exchange factor-like sequence
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2000066735A3 (en) Human ion channel proteins
EP1236800A3 (en) Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof
WO2005049793A3 (en) Methods and compositions for combinatorial approaches to cancer gene therapy
CA2348732A1 (en) Human h37 proteins and cdnas encoding the same
WO2002063009A3 (en) Lp mammalian proteins; related reagents
WO2003012120A3 (en) Lp354 mammalian secreted protein
BR9915537A (en) Prv-1 gene and its use
HUP0400915A2 (en) Plant reproduction proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003523642

Country of ref document: JP

122 Ep: pct application non-entry in european phase